These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22067143)

  • 1. Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist.
    Le DE; Bragadeesh T; Zhao Y; Wang YG; Zha D; Kaul S
    Eur Heart J Cardiovasc Imaging; 2012 Apr; 13(4):298-308. PubMed ID: 22067143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of regadenoson for assessing fractional flow reserve.
    Nair PK; Marroquin OC; Mulukutla SR; Khandhar S; Gulati V; Schindler JT; Lee JS
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1085-92. PubMed ID: 22017933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress.
    Porter TR; Adolphson M; High RR; Smith LM; Olson J; Erdkamp M; Xie F; O'Leary E; Wong BF; Eifert-Rain S; Hagen ME; Abdelmoneim SS; Mulvagh SL
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):628-35. PubMed ID: 21946702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of myocardial perfusion abnormalities using ultra-low radiation dose regadenoson stress multidetector computed tomography.
    Patel AR; Lodato JA; Chandra S; Kachenoura N; Ahmad H; Freed BH; Newby B; Lang RM; Mor-Avi V
    J Cardiovasc Comput Tomogr; 2011; 5(4):247-54. PubMed ID: 21723516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regadenoson Stress Real-Time Myocardial Perfusion Echocardiography for Detection of Coronary Artery Disease: Feasibility and Accuracy of Two Different Ultrasound Contrast Agents.
    Abdelmoneim SS; Mulvagh SL; Xie F; O'Leary E; Adolphson M; Omer MA; Nhola LF; Huang R; Warta SJ; Kirby B; Porter TR
    J Am Soc Echocardiogr; 2015 Dec; 28(12):1393-400. PubMed ID: 26416199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.
    Lieu HD; Shryock JC; von Mering GO; Gordi T; Blackburn B; Olmsted AW; Belardinelli L; Kerensky RA
    J Nucl Cardiol; 2007 Jul; 14(4):514-20. PubMed ID: 17679059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of regadenoson for measurement of fractional flow reserve.
    Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative three-dimensional evaluation of myocardial perfusion during regadenoson stress using multidetector computed tomography.
    Mor-Avi V; Lodato JA; Kachenoura N; Chandra S; Freed BH; Newby B; Lang RM; Patel AR
    J Comput Assist Tomogr; 2012; 36(4):443-9. PubMed ID: 22805675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regadenoson in the detection of coronary artery disease.
    Buhr C; Gössl M; Erbel R; Eggebrecht H
    Vasc Health Risk Manag; 2008; 4(2):337-40. PubMed ID: 18561509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regadenoson: a new myocardial stress agent.
    Al Jaroudi W; Iskandrian AE
    J Am Coll Cardiol; 2009 Sep; 54(13):1123-30. PubMed ID: 19761931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory.
    Stolker JM; Lim MJ; Shavelle DM; Morris DL; Angiolillo DJ; Guzman LA; Kennedy KF; Weber E; Zareh M; Neumayr RH; Zenni MM
    Cardiovasc Revasc Med; 2015; 16(5):266-71. PubMed ID: 26242981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
    Cerqueira MD; Nguyen P; Staehr P; Underwood SR; Iskandrian AE;
    JACC Cardiovasc Imaging; 2008 May; 1(3):307-16. PubMed ID: 19356442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET.
    Frey SM; Honegger U; Clerc OF; Caobelli F; Haaf P; Zellweger MJ
    J Nucl Cardiol; 2022 Jun; 29(3):921-933. PubMed ID: 34386864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regadenoson.
    Bengalorkar GM; Bhuvana K; Sarala N; Kumar TN
    J Postgrad Med; 2012; 58(2):140-6. PubMed ID: 22718059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regadenoson.
    Garnock-Jones KP; Curran MP
    Am J Cardiovasc Drugs; 2010; 10(1):65-71. PubMed ID: 20063904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.
    Palani G; Ananthasubramaniam K
    Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.